Literature DB >> 23986455

Diffusion-weighted MRI of metastatic liver lesions: is there a difference between hypervascular and hypovascular metastases?

Christine Schmid-Tannwald1, Stephen Thomas2, Marko K Ivancevic3, Farid Dahi2, Carsten Rist4, Ila Sethi2, Aytekin Oto2.   

Abstract

BACKGROUND: Different perfusion characteristics and histopathologic features of liver metastasis may potentially lead to different diffusion-weighted magnetic resonance imaging (DW-MRI) characteristics which can affect the performance of DW-MRI in their diagnosis.
PURPOSE: To compare ADC values of hypervascular and hypovascular metastases and the added value of DW-MRI to T2-weighted (T2-w) images in their detection.
MATERIAL AND METHODS: In this retrospective study, 46 patients (21 with hypervascular, 25 with hypovascular liver metastases) who had undergone abdominal MRI were included. Two independent observers first reviewed T2-w images only and then T2-w+DW-MR images and recorded number of metastases in each session. Lesion detection rate was compared using McNemar test. ADC of metastases in each patient was measured and compared between hypo- and hypervascular lesions using t-test.
RESULTS: A total of 153 hypervascular and 187 hypovascular metastases were detected at consensus review. Two observers detected significantly more hypervascular metastases on T2-w+DW-MR image review session compared to T2-w image only review session (reader 1: 148 [96.7%] vs. 129 [84.3%], P=0.002; reader 2: 125 [81.9%] vs. 113 [73.8%], P=0.004). Detection rate of hypovascular metastases was similar between two sessions for both observers (reader 1: 180 [96.2%] vs. 184 [98.4%]; reader 2: 176 [94.1%] vs. 180 [96.2%], P>0.05). The mean ADC value of hypervascular metastases was significantly lower than mean ADC value of hypovascular metastases (1.23+/-0.31 × 10(-3)mm(2)/s vs. 1.49+/-0.19 × 10(-3)mm(2)/s) (P=0.001).
CONCLUSION: Liver metastases are not a homogenous group of lesions with uniform DW-MRI features. Hypervascular metastases demonstrate significantly lower ADC values compared to hypovascular metastases. DW-MRI improved detection of hypervascular metastases compared to T2-w images alone and is a useful adjunct to T2-w images for their detection. © The Foundation Acta Radiologica 2013 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  ADC measurements; Diffusion-weighted MRI; hypovascular and hypovascular liver metastases

Mesh:

Substances:

Year:  2013        PMID: 23986455     DOI: 10.1177/0284185113501493

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  5 in total

1.  Liver segmentation and metastases detection in MR images using convolutional neural networks.

Authors:  Mariëlle J A Jansen; Hugo J Kuijf; Maarten Niekel; Wouter B Veldhuis; Frank J Wessels; Max A Viergever; Josien P W Pluim
Journal:  J Med Imaging (Bellingham)       Date:  2019-10-15

2.  [Gastroenteropancreatic endocrine tumors].

Authors:  C Schmid-Tannwald; C M Schmid-Tannwald; M F Reiser; F Berger
Journal:  Radiologe       Date:  2014-10       Impact factor: 0.635

Review 3.  Prognostication and response assessment in liver and pancreatic tumors: The new imaging.

Authors:  Riccardo De Robertis; Paolo Tinazzi Martini; Emanuele Demozzi; Gino Puntel; Silvia Ortolani; Sara Cingarlini; Andrea Ruzzenente; Alfredo Guglielmi; Giampaolo Tortora; Claudio Bassi; Paolo Pederzoli; Mirko D'Onofrio
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

4.  A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases.

Authors:  Valérie Vilgrain; Maxime Esvan; Maxime Ronot; Aurore Caumont-Prim; Christophe Aubé; Gilles Chatellier
Journal:  Eur Radiol       Date:  2016-02-16       Impact factor: 5.315

5.  Differential diagnostic value of computed tomography perfusion combined with vascular endothelial growth factor expression in head and neck lesions.

Authors:  Jie Wang; Zuohua Tang; Shuyi Wang; Wenjiao Zeng; Wen Qian; Lingjie Wu; Wenzhong Wang; Jianfeng Luo
Journal:  Oncol Lett       Date:  2016-04-05       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.